How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience

J Clin Oncol. 2005 Jun 20;23(18):4235-6; author reply 4236. doi: 10.1200/JCO.2004.00.8417.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Dacarbazine / administration & dosage
  • Dacarbazine / adverse effects*
  • Dacarbazine / analogs & derivatives*
  • Glioblastoma / drug therapy*
  • Humans
  • Lymphopenia / chemically induced*
  • Neoplasm Recurrence, Local
  • Survival Rate
  • Temozolomide
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide